From Sea to Relief: The Therapeutic Potential of Marine Algal Antioxidants in Pain Alleviation
Marine Drugs · 2025
DOI: 10.3390/md23070270 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Marine Drugs, 2025. Verfasst von Mariola Belda-Antolí und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Health Science, Department of Physiotherapy, Catholic University of Valencia, 46002 Valencia, Spain. Hauptthemen laut MEDLINE: Antioxidants, Aquatic Organisms, Phaeophyceae, Seaweed. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chronic pain affects approximately 20% of the global adult population, posing significant healthcare and economic challenges. Effective management requires addressing both biological and psychosocial factors, with emerging therapies such as antioxidants and marine algae offering promising new treatment avenues. Marine algae synthesize bioactive compounds, including polyphenols, carotenoids, and sulfated polysaccharides, which modulate oxidative stress, inflammation, and neuroimmune signaling pathways implicated in pain. Both preclinical and clinical studies support their potential application in treating inflammatory, neuropathic, muscular, and chronic pain conditions. Notable constituents include polyphenols, carotenoids (such as fucoxanthin), vitamins, minerals, and sulfated polysaccharides. These compounds modulate oxidative stress and inflammatory pathways, particularly by reducing reactive oxygen species (ROS) and downregulating cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). Brown and red algae produce phlorotannins and fucoidans that alleviate pain and inflammation in preclinical models. Carotenoids like fucoxanthin demonstrate neuroprotective effects by influencing autophagy and inflammatory gene expression. Algal-derived vitamins (C and E) and minerals (magnesium, selenium, and zinc) contribute to immune regulation and pain modulation. Additionally, sulfated polysaccharides suppress microglial activation in the central nervous system (CNS). Marine algae represent a promising natural source of bioactive compounds with potential applications in pain management. Although current evidence, primarily derived from preclinical studies, indicates beneficial effects in various pain models, further research is necessary to confirm their efficacy, safety, and mechanisms in human populations. These findings advocate for the continued exploration of marine algae as complementary agents in future therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine and Health Science, Department of Physiotherapy, Catholic University of Valencia, 46002 Valencia, Spain.
- Predepartamental Unit of Medicine, School of Health Sciences, Universitat Jaume I, 12006 Castellón de la Plana, Spain.
ORCID-Profile: Mariola Belda-Antolí, Francisco A Ros Bernal, Juan Vicente-Mampel
Zitieren
APA
Belda-Antolí, M., Ros Bernal, F. A., & Vicente-Mampel, J. (2025). From Sea to Relief: The Therapeutic Potential of Marine Algal Antioxidants in Pain Alleviation. Marine Drugs. https://doi.org/10.3390/md23070270
Vancouver
Belda-Antolí M, Ros Bernal FA, Vicente-Mampel J. From Sea to Relief: The Therapeutic Potential of Marine Algal Antioxidants in Pain Alleviation. Marine Drugs. 2025. doi:10.3390/md23070270
BibTeX
@article{BeldaAntol2025,
author = {Belda-Antolí, Mariola and Ros Bernal, Francisco A and Vicente-Mampel, Juan},
title = {From Sea to Relief: The Therapeutic Potential of Marine Algal Antioxidants in Pain Alleviation},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23070270}
}
EUVIMED